Sixty-six cases of intrauterine fetal death: A prospective study with an extensive test protocol

References

• Morrison I, Olsen J. Weight-specific stillbirths and associated causes of death: An analysis of 765 stillbirths. Am J Obstet Gynecol 1985; 152: 975–80
   PubMed Web of Science ®Google Scholar
• Alessandri L M, Stanley F J, Waddell V P, Newnham J. Stillbirths in Western Australia 1980–83: Influence of race, residence and place of birth. Aust NZ J Obstet Gynaecol 1988; 284–92
   Google Scholar
• Fretts R C, Boyd M E, Usher R H, Usher HA. The changing pattern of fetal death. 1961–88. Obstet Gynecol 1992; 79: 35–9
   PubMed Web of Science ®Google Scholar
• Baird D, Walker J, Thomson AM. The causes and prevention of stillbirths and first-week deaths. Part III. A classification of deaths by clinical cause: The effect of age parity and length of gestation on death rates by cause. J Obstet Gynaecol Br Emp 1954; 61: 433–48
   PubMedGoogle Scholar
• Baird D, Thomson AM. The survey perinatal deaths reclas-sified by special clinico-pathological assessment. Perinatal problems, N R Butler, D D Aldeman. Livingstone, London 1969; 200–10
   Google Scholar
• Harris EN. Maternal autoantibodies and pregnancy-I: The antiphospholipid antibody syndrome. Pregnancy and the Rheumatic Diseases, Vol. 4/Number 1, A L Parker. Baillière Tindall, London 1990; 53–67
   Google Scholar
• Rayburn W, Sander C, Barr M, Rygiel R. The stillborn fetus: placental histologic examination in determining a cause. Obstet Gynecol 1985; 65: 637–40
   PubMedGoogle Scholar
• Feinstein DI. Lupus anticoagulant, anticardio-lopin antibodies, fetal loss and systemic lupus erythemato-sus. Blood 1992; 80: 859–62, Editorial
   PubMedGoogle Scholar
• Feldman GB. Prospective risk of stillbirth. Obstet Gynecol 1992; 79: 547–53
   PubMed Web of Science ®Google Scholar
• Brandt C A, Holmskov A. The prevalence of prenatal death in the community of Viborg Denmark. Acta Obstet Gynecol Scand 1990; 69: 7–10
   Web of Science ®Google Scholar
• Jensen O H, Urnes A, Sornes T. Intrauterine death: Evaluation of 6-year material from a central hospital. Tidsskr Nor Laegeforen 1988; 108: 915–8
   Google Scholar
• Brans Y W, Escobedo M B, Hayashi R H, Huff R W, Kagan-Hallet K S, Ramamurthy RS. Perinatal mortality in a large perinatal center: Five-year review of 31,000 births. Am J Obstet Gynecol 1984; 148: 284–9
   PubMed Web of Science ®Google Scholar
• Magani I M, Rafla N M, Mortimer G, Meehan FI. Stillbirths: a clinicopathological survey (1972–82). Pediatr Pathol 1990; 10: 363–74
   PubMedGoogle Scholar
• Widjaja A H, Mantell CD. Stillbirths in Auckland 1983–86. NZ Med J 1988; 101: 768–770
   Google Scholar
• Editorial. Unexplained stillbirth. Lancet 1987; 1: 22–3
   Google Scholar
• Kriel R L, Gates G A, Wulff H, Powell N, Poland J D, Chin T DY. Cytomegalovirus isolations associated with pregnancy wastage. Am J Obstet Gynecol 1970; 106: 885–92
   Google Scholar
• Marquis J R, Jung KL. Extensive central nervous system calcification in a stillborn male infant due to cytomegalovirus infection. Am J Roentgenol 1976; 127: 665–7
   Google Scholar
• Perlman J M, Argyle C. Lethal cytomegalovirus infection in preterni infants: clinical, radiological, and neuropatho-logical findings. Ann Neurol 1992; 31: 64–8
   PubMed Web of Science ®Google Scholar
• Lewis P E, Cefalo R C, Zaritsky AL. Fetal heart block caused by cytomegalovirus. Am J Obstet Gynecol 1980; 136: 967–8
   Google Scholar
• Karn K, Julian T M, Ogburn PL. Fetal heart block associated with congenital CMV infection. J Reprod Med 1984; 29: 278–80
   Google Scholar
• Ahlfors K, Harris S, Ivarsson S, Svanberg L. Secondary maternal cytomegalovirus infection causing symptomatic congenital infection. N Engl J Med 1981; 305: 284
   PubMed Web of Science ®Google Scholar
• Ahlfors K, Forsgren M, Ivarsson S A, Harris S, Svanberg L. Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis 1983; 15: 129–38
   PubMed Web of Science ®Google Scholar
• Rutter D, Griffiths P, Trompeter RS. Cytomegalic inclusion disease after recurrent maternal infection. Lancet 1985; 2: 1182
   Google Scholar
• Brady M WK, Purdon MA. Intrauterine fetal demise associated with enterovirus infection. South Med J 1986; 79: 770–2
   Google Scholar
• Yawn D H, Pyeatte J C, Joseph J M, Eichler S L, Garcia-Bunuel R. Transplacental transfer of influenza virus. JAMA 1971; 216: 1022–3
   PubMed Web of Science ®Google Scholar
• Person K, Bjerre B, Elfstrom L, Forsgren A. Longitudinal study of group B streptococcial carriage during late pregnancy. Scand J Infect Dis 1987; 19: 325–9
   Google Scholar
• De Wolf F, Carreras L O, Moerman P, Vermylen J, Van Assdhe A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboem-bolic accidents recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829–34
   PubMed Web of Science ®Google Scholar
• Branch D W, Scott J R, Kochenour N K, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1332–6
   Web of Science ®Google Scholar
• Silver M M, Laxer R M, Laskin C A, Smallhorn J F, Gare DJ. Association of fetal health block and massive placental infarction due to maternal autoantibodies. Pediatr Pathol 1992; 12: 131–9
   PubMed Web of Science ®Google Scholar
• Perez M C, Wilson W A, Brown H L, Scopelitis E. Anticardi-olipin antibodies in unselected pregnant women: Relationship to fetal outcome. J Perinatol 1991; 11: 33–6
   PubMedGoogle Scholar
• Lockwood C J, Romero R, Feinberg R F, Clyne L P, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369–73
   PubMed Web of Science ®Google Scholar
• Haddow J E, Rote N S, Dostal-Johnson D, Palomaki G, Pulkkinen A, Knight G. Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester. Am J Obstet Gynecol 1991; 165: 1308–12
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med 1991; 325: 1063
   PubMed Web of Science ®Google Scholar
• Bagger P V, Andersen V, Baslund B. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE. Acta Obstet Gynecol Scand 1993; 72: 465–9
   Web of Science ®Google Scholar
• Harley J B, Kaine J L, Fox O F, Reichlin M, Gruber B. Ro (SS-A) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum 1985; 28: 1321–5
   PubMedGoogle Scholar
• Harris NE. A reassessment of the antiphospholipid syndrome. J Rheumatol 1990; 17: 733–5, Editorial
   PubMed Web of Science ®Google Scholar
• Landy H J, Kessler C, Kelly W K, Weingold AB. Obstetric performance in patients with the lupus anticoagulant and/ or anticardiolipin antibodies. Am J Perinatol 1992; 9: 146–51
   PubMedGoogle Scholar
• Branch DW. Antiphospholipid antibodies and pregnancy: Maternal implications. Semin Perinatol 1990; 14: 13946
   Google Scholar
• Lee LA. Maternal autoantibodies and pregnancy-II: The neonatal lupus syndrome. Pregnancy and the Rheumatic Diseases, Vol. 4/Number 1, A L Parker. Bailliere Tindall, London 1990; 69–83
   Google Scholar
• Buyton J, Roubey R, Swersky S. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol 1988; 15: 1104–8
   Google Scholar
• Herreman G, Galezewski N. Maternal connective tissue disease and congenital heart block (letter). N Engl J Med 1985; 312: 1329
   PubMed Web of Science ®Google Scholar
• Buyon J, Swersky S, Fox H, Bierman F, Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus: experience in a mother with a predominance of SSB (LA) antibodies. Arthritis Rheum 1987; 30: 44–9
   PubMed Web of Science ®Google Scholar
• McCune A B, Weston W L, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987; 106: 518–23
   PubMed Web of Science ®Google Scholar
• Belfrage P, Thomassen P, Floberg J, Åkerblom O, Brober-Ger U. Alloimmunization during pregnancy. Clinical results from 1983 to 1989 in a Scandinavian University Hospital. Acta Obstet Gynecol Scand 1992; 71: 273–7
   Web of Science ®Google Scholar
• Marions L, Thomassen P. Six cases of massive feto-maternal bleeding causing intra-uterine fetal death. Acta Obstet Gynecol Scand 1991; 70: 85–8
   PubMed Web of Science ®Google Scholar
• Hinchliffe S A, Sargent P H, Howard CY, Chan Y F, Van Vel-Zen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99: 296–301
   PubMedGoogle Scholar